Oxidative in Medical Technology
Navigation Links
Oxidative in Medical Technology
... "metabolic syndrome." Low level inflammation and oxidative stress are the mechanistic underpinnings of ... The Cardax drug reduces systemic inflammation and oxidative stress while localizing in the liver and the ... the source of inflammation, intracellular oxidative stress," said David G. Watumull, CEO of Cardax. ...
... that rooibos tea protects the body against oxidative damage, as seen by the approximate 21% ... The trial (entitled "Modulation of blood oxidative stress markers and DNA damage by rooibos tea in ... L. Marnewick, Ph.D., senior researcher at the oxidative Stress Research Centre at Cape Peninsula ...
... at high levels of reactive oxygen species, or oxidative stress. Elesclomol is believed to act by increasing the level of oxidative stress in cancer cells even further, beyond ... This mechanism of action, called oxidative stress induction, represents a novel way of ...
... RNA interference, or RNAi, for the treatment of diseases associated with oxidative stress. Quark believes that its proprietary target gene discovery ... concepts discovered using BiFAR(TM) and designed for the treatment of oxidative stress associated diseases of the inner ear, lungs and additional organs ...
... that treatment of cells in cultures with ONCONASE reduced intracellular oxidative stress by suppressing ROI generation and promoting their degradation. ... not only for cancer, but for conditions pathogenetically related to oxidative stress or the activation of NF-kappa B, such as inflammation, autoimmune ...
... RNA interference, or RNAi, for the treatment of diseases associated with oxidative stress. Quark believes that its proprietary target gene discovery ... concepts discovered using BiFAR(TM) and designed for the treatment of oxidative stress associated diseases of the inner ear, lungs and additional organs ...
... RNA interference, or RNAi, for the treatment of diseases associated with oxidative stress. Quark believes that its proprietary target gene discovery ... concepts discovered using BiFAR(TM) and designed for the treatment of oxidative stress associated diseases of the inner ear, lungs and additional organs ...
... across the U.S., Canada, Europe and India. Alimera also has entered into an exclusive worldwide agreement with Emory University to explore oxidative stress management -- specifically the reduction of reactive oxygen species (ROS) -- as a treatment strategy for ophthalmic diseases. Under this ...
... across the U.S., Canada, Europe and India. Alimera also has entered into an exclusive worldwide agreement with Emory University to explore oxidative stress management -- specifically the reduction of reactive oxygen species (ROS) -- as a treatment strategy for ophthalmic diseases. Under this ...
... a combined total enrollment of 956 patients. Alimera also has entered into an exclusive worldwide agreement with Emory University to explore oxidative stress management -- specifically the reduction of reactive oxygen species (ROS) -- as a treatment strategy for ophthalmic diseases. Under this ...
... with a combined total enrollment of 956 patients. Alimera also has entered into an exclusive worldwide agreement with Emory University to explore oxidative stress management -- specifically the reduction of reactive oxygen species (ROS) -- as a treatment strategy for ophthalmic diseases. Under this ...
... released from red blood cells. Extracellular hemoglobin (hemoglobin not found in red blood cells) is a potent oxidizing agent capable of inflicting oxidative tissue damage. Haptoglobin binds to this extracellular hemoglobin and inhibits hemoglobin induced oxidation. Once hemoglobin is bound to haptoglobin, ...
... stress, not amyloid-beta, is the cause of Alzheimer's. ANAVEX 1-41 uses sigma receptors, a unique class of receptor molecules, to guard against oxidative stress and repair cells compromised by its effects. So far, through the advanced pre-clinical phase of development, the compound has performed ...
... 201 showed that SYI-2074, in Hp2-2 diabetic patients, did not demonstrate a dose-related improvement in all oxidized lipids and all markers of oxidative stress after one month. In Trial 203, SYI-2074 did not provide evidence of protection against cardiac injury in diabetic patients who were undergoing ...
... the control of cell survival/proliferation signals and in cancer. SF1126 is the only PI3K inhibitor demonstrated in preclinical studies to cause an oxidative stress mechanism in cancer cells, resulting in decreased proliferation and apoptosis. A major factor in tumor resistance to approved ...
... and nutrients from blood creates a condition in which the restoration of blood flow results in inflammation and damage through the induction of oxidative stress, caused by the production of reactive oxygen species. Reperfusion injury is due in part to the inflammatory response of damaged tissues. White ...
... for the treatment of diabetic macular edema. Alimera has also has entered into an exclusive worldwide agreement with Emory University to explore oxidative stress management -- specifically the reduction of reactive oxygen species (ROS) -- as a treatment for ophthalmic diseases. The agreement gives ...
... treatment of melanoma for which there have been no new treatments approved in the last decade." Amplimexon is a small molecule drug that increases oxidative stress in tumor cells leading to mitochondrial damage and apoptosis. In preclinical in vitro and animal model studies it shows activity against human ...
... SHP-2 modulate progenitor cell development, cellular growth, tissue inflammation, cellular chemotaxis, and directly control cell survival involving oxidative stress pathways. SHP-1 and SHP-2 are fundamental for the function of several growth factor and metabolic pathways with far reaching implications for ...
... believes that accumulation of AGEs might prove to be a promising, novel target for the treatment of heart failure. AGEs are proteins formed by oxidative or non-oxidative reactions. AGEs cause the formation of collagen cross-links, which result in increased myocardial stiffness whereby the stiff ...
... candidate portfolio of RNAi therapeutics based on novel targets and therapeutic concepts discovered using BiFAR(TM) and designed for the treatment of oxidative stress associated diseases of the inner ear, lungs and additional organs of the body. Quark is headquartered in Fremont, California and operates ...
... expertise in Child Health, Pulmonary Disease and oxidative Stress research, plus access to patients ... for the first time, that there was high levels of oxidative stress in the lungs. In addition, we treated the increased oxidative stress by using of an antioxidant, N-acetyl ...
... and clinical development that target: 1) PARP, a nuclear enzyme that is fundamental to DNA repair and inflammation; 2) peroxynitrite, a highly toxic oxidative and nitrosative species produced by cells in response to injury; and 3) the purinergic receptor family, with a specific focus on adenosine receptors. ...
... and clinical development that target: 1) PARP, a nuclear enzyme that is fundamental to DNA repair and inflammation; 2) peroxynitrite, a highly toxic oxidative and nitrosative species produced by cells in response to injury; and 3) the purinergic receptor family, with a specific focus on adenosine receptors. ...
... potential (MTP) leading to the release of reactive oxygen species, causing inhibition of glycolysis and ending with induction of oxidative DNA damage. A paper on BZL101's mechanism of action and unique selective properties based on the company's initial Phase 1 clinical trial was ...
... side effect. "We were impressed by the broad spectrum effect of Othera's compounds in terms of their ability to inhibit not only genes involved in oxidative stress responses, but also inflammatory response genes that control angiogenesis," said Dr. Mousa. "These clues pointed us towards a more complex ...
... that rooibos tea protects the body against oxidative damage, as seen by the approximate 21% ... The trial (entitled "Modulation of blood oxidative stress markers and DNA damage by rooibos tea in ... L. Marnewick, Ph.D., senior researcher at the oxidative Stress Research Centre at Cape Peninsula ...
... at high levels of reactive oxygen species, or oxidative stress. Elesclomol is believed to act by increasing the level of oxidative stress in cancer cells even further, beyond ... This mechanism of action, called oxidative stress induction, represents a novel way of ...
Mayo Clinic Discovery May Help Diabetic Gastric Problem
... tract. Both are important for normal functioning but can be depleted by oxidative stress (an imbalance in ionic charges at the molecular level), a problem ... research team decided to test a molecule known to protect cells against oxidative injury -- heme oxygenase-1 (HO1). The team measured gastric emptying in a ...Resveratrol Longevity Science Makes Dramatic U-Turn, But Resveratrol Supplements Remain Unchanged
... failure by more than 7.5 fold. [Sirt1 regulates aging and resistance to oxidative stress in the heart. Circulation Research 2007; 100: 1512-21] -- While ... of biological processes, including metabolism, cell proliferation, and oxidative stress response, may play a stronger role than the Sirtuin1 gene in ...ViaViente Demonstrates Cardiovascular Benefits in New Human Trial
... a daily intake of anti-oxidants, especially in their natural form. oxidative stress causes damage to cells and contributes to aging and disease. Anti-oxidants combat effects of oxidative stress such as inflammation. A recent independent report, A Consumer ...Antipodean Pharmaceuticals Announces Completion of Phase 2 Study of Lead Compound MitoQ(R)
... a mitochondria-targeted antioxidant that selectively blocks mitochondrial oxidative damage and prevents liver cell apoptosis. MitoQ(R) is based on a novel ... pharmaceutical company developing targeted molecules that prevent oxidative damage to endothelial, epithelial and liver cells leading to apoptosis and ...... RNA interference, or RNAi, for the treatment of diseases associated with oxidative stress. Quark believes that its proprietary target gene discovery ... concepts discovered using BiFAR(TM) and designed for the treatment of oxidative stress associated diseases of the inner ear, lungs and additional organs ...
... that treatment of cells in cultures with ONCONASE reduced intracellular oxidative stress by suppressing ROI generation and promoting their degradation. ... not only for cancer, but for conditions pathogenetically related to oxidative stress or the activation of NF-kappa B, such as inflammation, autoimmune ...
... RNA interference, or RNAi, for the treatment of diseases associated with oxidative stress. Quark believes that its proprietary target gene discovery ... concepts discovered using BiFAR(TM) and designed for the treatment of oxidative stress associated diseases of the inner ear, lungs and additional organs ...
... RNA interference, or RNAi, for the treatment of diseases associated with oxidative stress. Quark believes that its proprietary target gene discovery ... concepts discovered using BiFAR(TM) and designed for the treatment of oxidative stress associated diseases of the inner ear, lungs and additional organs ...
... across the U.S., Canada, Europe and India. Alimera also has entered into an exclusive worldwide agreement with Emory University to explore oxidative stress management -- specifically the reduction of reactive oxygen species (ROS) -- as a treatment strategy for ophthalmic diseases. Under this ...
AACR Data Highlights InNexus Preclinical Antibody Candidate
... Cytotoxicity Shows No Systemic Toxicity In The Cynomolgus Monkey At A Dose 100-Fold Above The Anticipated Therapeutic Dose ", (AACR# 1231) and " oxidative Modification Of An Anti-CD20 Antibody Imparts Autophilic Binding Kinetics ", (AACR# 1230). Posters and company representatives will also be ...... across the U.S., Canada, Europe and India. Alimera also has entered into an exclusive worldwide agreement with Emory University to explore oxidative stress management -- specifically the reduction of reactive oxygen species (ROS) -- as a treatment strategy for ophthalmic diseases. Under this ...
... a combined total enrollment of 956 patients. Alimera also has entered into an exclusive worldwide agreement with Emory University to explore oxidative stress management -- specifically the reduction of reactive oxygen species (ROS) -- as a treatment strategy for ophthalmic diseases. Under this ...
Grapes May Aid a Bunch of Heart Risk Factors, U-M Animal Study Finds
... the grape-fed rats had improved cardiac output, or more blood pumped per unit of time. The researchers also looked for signs of inflammation, oxidative damage and other molecular indicators of cardiac stress. Again, the rats that received the high-salt grape diet had lower levels of these markers ...Alimera Reports Results From the Six-Month Interim Readout of the Human PK Iluvien(TM) Study
... with a combined total enrollment of 956 patients. Alimera also has entered into an exclusive worldwide agreement with Emory University to explore oxidative stress management -- specifically the reduction of reactive oxygen species (ROS) -- as a treatment strategy for ophthalmic diseases. Under this ...... with a combined total enrollment of 956 patients. Alimera also has entered into an exclusive worldwide agreement with Emory University to explore oxidative stress management -- specifically the reduction of reactive oxygen species (ROS) -- as a treatment strategy for ophthalmic diseases. Under this ...
... released from red blood cells. Extracellular hemoglobin (hemoglobin not found in red blood cells) is a potent oxidizing agent capable of inflicting oxidative tissue damage. Haptoglobin binds to this extracellular hemoglobin and inhibits hemoglobin induced oxidation. Once hemoglobin is bound to haptoglobin, ...
... stress, not amyloid-beta, is the cause of Alzheimer's. ANAVEX 1-41 uses sigma receptors, a unique class of receptor molecules, to guard against oxidative stress and repair cells compromised by its effects. So far, through the advanced pre-clinical phase of development, the compound has performed ...
Kiwifruit: Antioxidant Power in Quantity and Quality
... Ronald Prior and his team measured the antioxidants in the body by noting increases in blood antioxidant capacity and cells' increased resistance to oxidative damage induced by hydrogen peroxide. To test kiwifruit's antioxidant capacity, seven healthy women were given two servings of green Hayward ...Alimera Reports Results From the Three-Month Interim Readout of the Human PK Medidur(TM) FA Study
... with a combined total enrollment of 956 patients. Alimera also has entered into an exclusive worldwide agreement with Emory University to explore oxidative stress management -- specifically the reduction of reactive oxygen species (ROS) -- as a treatment strategy for ophthalmic diseases. Under this ...... 201 showed that SYI-2074, in Hp2-2 diabetic patients, did not demonstrate a dose-related improvement in all oxidized lipids and all markers of oxidative stress after one month. In Trial 203, SYI-2074 did not provide evidence of protection against cardiac injury in diabetic patients who were undergoing ...
... the control of cell survival/proliferation signals and in cancer. SF1126 is the only PI3K inhibitor demonstrated in preclinical studies to cause an oxidative stress mechanism in cancer cells, resulting in decreased proliferation and apoptosis. A major factor in tumor resistance to approved ...
... and nutrients from blood creates a condition in which the restoration of blood flow results in inflammation and damage through the induction of oxidative stress, caused by the production of reactive oxygen species. Reperfusion injury is due in part to the inflammatory response of damaged tissues. White ...
... for the treatment of diabetic macular edema. Alimera has also has entered into an exclusive worldwide agreement with Emory University to explore oxidative stress management -- specifically the reduction of reactive oxygen species (ROS) -- as a treatment for ophthalmic diseases. The agreement gives ...
... treatment of melanoma for which there have been no new treatments approved in the last decade." Amplimexon is a small molecule drug that increases oxidative stress in tumor cells leading to mitochondrial damage and apoptosis. In preclinical in vitro and animal model studies it shows activity against human ...
... SHP-2 modulate progenitor cell development, cellular growth, tissue inflammation, cellular chemotaxis, and directly control cell survival involving oxidative stress pathways. SHP-1 and SHP-2 are fundamental for the function of several growth factor and metabolic pathways with far reaching implications for ...
Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
... drug candidates that work through the natural mechanism in the cell known as RNA interference, or RNAi, for the treatment of diseases associated with oxidative stress. Quark believes that its proprietary target gene discovery platform, BiFARTM, combined with its ability to design and successfully deliver ...... believes that accumulation of AGEs might prove to be a promising, novel target for the treatment of heart failure. AGEs are proteins formed by oxidative or non-oxidative reactions. AGEs cause the formation of collagen cross-links, which result in increased myocardial stiffness whereby the stiff ...
New Study: Pine Bark Extract Boosts Nitric Oxide (NO) Production
... of the study. "These results also lead me to determine that Pycnogenol(R) will be a useful natural alternative therapy in various diseases in which oxidative stress is involved in the pathogenesis." The double-blind, randomized, placebo study was held at the Hiroshima University Graduate School of ...Quark Pharmaceuticals Appoints New Chief Medical Officer
... drug candidates that work through the natural mechanism in the cell known as RNA interference, or RNAi, for the treatment of diseases associated with oxidative stress. Quark believes that its proprietary target gene discovery platform, BiFAR(TM), combined with its ability to design and successfully deliver ...... candidate portfolio of RNAi therapeutics based on novel targets and therapeutic concepts discovered using BiFAR(TM) and designed for the treatment of oxidative stress associated diseases of the inner ear, lungs and additional organs of the body. Quark is headquartered in Fremont, California and operates ...
... expertise in Child Health, Pulmonary Disease and oxidative Stress research, plus access to patients ... for the first time, that there was high levels of oxidative stress in the lungs. In addition, we treated the increased oxidative stress by using of an antioxidant, N-acetyl ...
... and clinical development that target: 1) PARP, a nuclear enzyme that is fundamental to DNA repair and inflammation; 2) peroxynitrite, a highly toxic oxidative and nitrosative species produced by cells in response to injury; and 3) the purinergic receptor family, with a specific focus on adenosine receptors. ...
The Sturdier Sex?: Study by Pittsburgh Scientists Finds Female Stem Cells Work Better
... to a much more significant level of skeletal muscle regeneration," she said. "The male cells exhibited increased differentiation after exposure to oxidative stress, which may lead to cell depletion and a proliferative advantage for female cells after cell transplantation." Dr. Huard is an ...... and clinical development that target: 1) PARP, a nuclear enzyme that is fundamental to DNA repair and inflammation; 2) peroxynitrite, a highly toxic oxidative and nitrosative species produced by cells in response to injury; and 3) the purinergic receptor family, with a specific focus on adenosine receptors. ...
... potential (MTP) leading to the release of reactive oxygen species, causing inhibition of glycolysis and ending with induction of oxidative DNA damage. A paper on BZL101's mechanism of action and unique selective properties based on the company's initial Phase 1 clinical trial was ...
... side effect. "We were impressed by the broad spectrum effect of Othera's compounds in terms of their ability to inhibit not only genes involved in oxidative stress responses, but also inflammatory response genes that control angiogenesis," said Dr. Mousa. "These clues pointed us towards a more complex ...
Other ContentsfistulaflatulenceflatulencefitsfitsfitsfitsfitsfitsfitsflankflankflankflatflatflatflatflatflatflatflatfolliculitisOther TagsHelicalCoudeBARDEXSpiralOther Tagsexposure 2exposure 3exposure 4exposure 5exposure 6exposure 7exposure 8exposure 9exposure 10antenatal 2antenatal 3superior 2superior 3superior 4superior 5superior 6rhythm 2rhythm 3rhythm 4rhythm 5calm 2calm 3calm 4agreement 2agreement 3vegetables 2
(Date:12/14/2009)... from the Astrobiology Centre (INTA-CSIC) has shown that hydrogen ... formation of the most basic biological molecules can be ... carry out this study, published in the journal ... conditions of the early Earth. , "We have shown ... it produces hydrogen cyanide, a substance that could have ...
(Date:12/14/2009)... preventing some of the stresses of open surgery on the ... organ dysfunction. Laparoscopy is a type of surgery in the ... By adding another gas to the carbon dioxide used to ... Medical Center have found they can preserve more normal blood ... (ENO) helped to open blood vessels and keep blood flowing, ...
(Date:12/13/2009)... are associated with the health of the human lung. ... from 63 centres in Europe and Australia sheds new ... The new findings provide hope for better treatment for ... asthma. In the past it has been difficult to ... the health of the lung are not completely understood. ...
Breaking Biology News(10 mins):Prussian blue linked to the origin of life 2Gas improves blood flow and organ status during minimally invasive surgery 2New genes for lung disease discovered 2Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to Co Develop and Commercialize Compounds for Obesity 60478 1Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to Co Develop and Commercialize Compounds for Obesity 60478 2Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to Co Develop and Commercialize Compounds for Obesity 60478 3Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to Co Develop and Commercialize Compounds for Obesity 60478 4Duke develops nano scale drug delivery for chemotherapy 10597 1Duke develops nano scale drug delivery for chemotherapy 10597 2Study spotlights efficacy of questionnaire to identify patients at high risk for lung cancer 60475 1(Date:12/15/2009)... Preserving State Authority, Ban on Annual Benefit Limits, ... 15 Consumer Watchdog condemned the removal ... 55 and the public option from the U.S. ... that the Senate must still make three essential ... ceding the entire health care system to the ...
(Date:12/15/2009)... Alto Networks(TM), the network security company, today announced ... next-generation firewalls for accurate threat prevention on its ... over applications such as peer-to-peer file sharing. ,, ... eight facilities on five campuses. The university was ... academic schools and institutions throughout Japan. It is ...
(Date:12/15/2009)... WASHINGTON, Dec. 15 Our Lady of Lourdes ... New Jersey hospitals, has agreed to pay the United ... defrauded Medicare, the Justice Department announced today. The two ... in Camden, N.J., and Lourdes Medical Center of Burlington ... a defendant in a suit brought by a whistleblower, ...
(Date:12/15/2009)... levels of leptin associated with lower dementia risk, research ... blood levels of leptin, a hormone that regulates appetite, ... "Hopefully, in 10 or 15 years this may be ... the risk of Alzheimer,s disease," said senior study author ... Boston University School of Medicine. "Or it may be ...
(Date:12/15/2009)... have released some sobering statistics concerning the parallel rise in diabetes ... an effective means of combating this trend afflicting their workforce. ... ... of diabetes are climbing across America due in large part to ... American Diabetes Association has stated that the rate of diabetes could ...
Breaking Medicine News(10 mins):Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 2Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 3Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 4Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 5Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 2Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 3Health News:Parent Company of Two New Jersey Hospitals to Pay U.S. $7.95 Million to Settle False Claims Act Allegations 2Health News:Fat Hormone May Protect Against Alzheimer's 2Health News:Fat Hormone May Protect Against Alzheimer's 3Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 2Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 3[1] The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System[1] Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University[0] Parent Company of Two New Jersey Hospitals to Pay U.S. $7.95 Million to Settle False Claims Act Allegations[0] Fat Hormone May Protect Against Alzheimer's[2] TrekDesk: A Potentially Positive Impact on Diabetes & Obesity
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |